Rankings
▼
Calendar
SRPT FY 2021 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
FY 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$702M
+30.0% YoY
Gross Profit
$605M
86.2% margin
Operating Income
-$460M
-65.5% margin
Net Income
-$419M
-59.7% margin
EPS (Diluted)
$-5.15
Cash Flow
Operating Cash Flow
-$443M
Free Cash Flow
-$482M
Stock-Based Comp.
$114M
Balance Sheet
Total Assets
$3.1B
Total Liabilities
$2.2B
Stockholders' Equity
$928M
Cash & Equivalents
$2.1B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$702M
$540M
+30.0%
Gross Profit
$605M
$477M
+26.9%
Operating Income
-$460M
-$564M
+18.5%
Net Income
-$419M
-$554M
+24.4%
← Q4 2020
All Quarters
Q1 2021 →